The hemodialysis blood tubing sets market was valued at USD 1,654.0 Mn by 2019. Rising prevalence of end-stage renal diseases worldwide primarily drives the hemodialysis blood tubing sets market growth. Additionally, the growing incidence of electrolyte and acid-base imbalance in patients suffering from chronic kidney disease further accentuates the market growth.

Hemodialysis blood tubing sets comprises of arterial lines and venous lines, wherein the arterial lines are used to transport the blood from patients to the hemodialysis machine and the venous lines ensure in bringing the blood back from the hemodialyzer to the patient. The majority of the hemodialysis blood tubing sets have needle stick injury protecting guards and medication ports. Rampant growth observed in the homecare settings and rehabilitation centers has led to an increase in the demand for hemodialysis blood tubing sets to treat patients suffering from kidney complications.

The major segments related to the hemodialysis blood tubing sets market are: 

By Clinical Application (2017–2027; US$ Mn)

Detoxification

Mineral Balance

Others

By End User (2017–2027; US$ Mn)

Hospital & Clinics

Ambulatory Surgical Center

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

• The intention of the study is to give a comprehensive outlook of the global hemodialysis blood tubing sets market
• The overall segmentation of the hemodialysis blood tubing sets market, by clinical application, end-user, and geography are minutely studied. Detoxification and hospital & clinic are dominating the clinical application and end-user segments respectively
• Rising prevalence of kidney complications worldwide
• Significant increase in the number of patients suffering from diabetic nephropathy across the globe further accentuates the market growth

Report gist?

• The study of the global hemodialysis blood tubing sets market includes qualitative analysis of factors such as drivers, restraints, and opportunities
• The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and end-user and categorization of the same at geography level
• This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

• This study is suitable for industry participants and stakeholders in the medical devices actively engaged in the production and marketing of hemodialysis blood tubing sets due to the rising prevalence of end-stage renal diseases worldwide
• The report will benefit nephrologist engaged in the hemodialysis of patients suffering from diabetic nephropathy throughout the globe
• Managers with financial institutions looking to publish recent and forecasted statistics pertaining to hemodialysis blood tubing sets market
• Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Detoxification is presently leading the clinical application segment for hemodialysis blood tubing sets market. As per the recent research citings provided by the World Health Organization (WHO), it is estimated that annually approximately 2 million patients are reported to be suffering from end-stage renal diseases (ESRD) worldwide. The mineral balance will be showcasing comfortable market growth in the near future owing to the significant increase in the number of patients suffering from the electrolyte and acid-base disorders due to chronic kidney disease.

Hospitals and clinics are presently dominating the end-user segment for hemodialysis blood tubing sets market. A significant increase in the number of individuals suffering from end-stage renal diseases in the developed regions has led to a concomitant increase in the patient’s visits to primary healthcare centers for hemodialysis on a regular basis. Ambulatory surgical centers are expected to harness positive market growth during the forecast period on account of the proactive initiatives adopted by the government healthcare agencies to promote ambulatory surgical centers to reduce the healthcare burden associated with the point of care centers across the globe.

North America is the supreme leader in the geography segment for hemodialysis blood tubing sets market. Significant increase in the number of patients suffering from end-stage renal diseases primarily drives the market growth in the region. As per the latest research citings provided by the National Institute of Health (NIH), approximately, 750,000 patients in the United States are reported to be suffering from end-stage renal diseases annually. Additionally, the nurturing regulatory environment provided by the USFDA regarding the sale and distribution of hemodialysis blood tubing sets further propels the market growth in the region. Europe is the second-largest regional segment for hemodialysis blood tubing sets market on account of the domicile of key players such as Fresenius Kabi, Baxter AG, Nipro Corporation, etc. The Asia Pacific is anticipated to be the fastest-growing regional segment for hemodialysis blood tubing sets market chiefly due to the growing incidence of diabetic nephropathy in elderly patients and increasing the medical tourism industry.